- Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Kenemans, P., Bundred, N.J., Foidart, J.M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C.H., Egberts, J., Mol-Arts, M., Mulder, R., van Os, S., Beckmann, M.W. Lancet Oncol. (2009)